Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01689987. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02176213. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Vorinostat Plus Melphalan and Prednisone (Zmp) in Advanced, Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT00857324. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma
ClinicalTrials.gov study NCT06158269. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06132711. IPD Sharing: NO. Countries: 1. Publications: 0.
CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04758767. IPD Sharing: NO. Countries: 2. Publications: 0.
Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00693433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IMMUNOPLANT for Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT06376526. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03672318. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies.
ClinicalTrials.gov study NCT01070862. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00047203. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial
ClinicalTrials.gov study NCT06228794. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients
ClinicalTrials.gov study NCT06682156. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ASCT With Nivolumab in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT03292263. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of 4 Bone Turnover Markers in Patients With Multiple Myeloma Treated With Intravenous Bisphosphonate in Routine Care
ClinicalTrials.gov study NCT04111809. IPD Sharing: NO. Countries: 1. Publications: 0.
Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
ClinicalTrials.gov study NCT07200089. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02773550. IPD Sharing: NO. Countries: 1. Publications: 0.
SST0001 (Roneparstat) in Advanced Multiple Myeloma
ClinicalTrials.gov study NCT01764880. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma
ClinicalTrials.gov study NCT07090954. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma
ClinicalTrials.gov study NCT01163357. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.